Multidisciplinary Management of Sleep Disorders

OSA Diagnosis & Team Approach - Sleep Disorder Squad

• Obstructive Sleep Apnea (OSA): Recurrent upper airway collapse in sleep.
  • AHI: Mild 5-15, Moderate 15-30, Severe >30 events/hr.
• Symptoms: Loud snoring, daytime sleepiness (EDS), witnessed apneas.
• Risks: Obesity (BMI >30), male, age >40, neck >40cm.
• 📌 STOP-BANG: Snoring, Tired, Observed apnea, Pressure (BP), BMI >35, Age >50, Neck >40cm, Gender male.

Diagnostic Tools:

• Polysomnography (PSG): Records AHI, RDI, SaO2 nadir.

  ⭐ Polysomnography (PSG) is the gold standard for OSA diagnosis.

• Epworth Sleepiness Scale (ESS): Score >10 indicates significant sleepiness.

Multidisciplinary Team (MDT):

Non-Surgical Management - Gentle Sleep Guardians

• Lifestyle Modifications:
  • Weight loss: Target 10% reduction improves Apnea-Hypopnea Index (AHI).
  • Regular exercise.
  • Avoid alcohol/sedatives, especially 3-4 hours before sleep.
  • Sleep hygiene: Consistent schedule, cool dark room.
  • Positional therapy (e.g., tennis ball technique) for supine-dependent OSA.
• Positive Airway Pressure (PAP) Therapy:
  • CPAP (Continuous PAP): First-line for moderate-severe OSA. Mechanism: Pneumatic splint for upper airway.
  • APAP (Auto-titrating PAP), BiPAP (Bilevel PAP) for specific cases/intolerance.
  • Common side effects: Mask discomfort, nasal dryness/congestion. Adherence strategies vital.
• Oral Appliances (OA):
  • Mandibular Advancement Devices (MAD), Tongue Retaining Devices (TRD).
  • Indications: Mild-moderate OSA, CPAP intolerance/refusal.
  • Mechanism: MADs advance mandible, TRDs hold tongue forward. Custom-fitted by dentist.
• Pharmacotherapy (Adjunctive, Limited Role):
  • Modafinil: For residual excessive daytime sleepiness in CPAP-compliant OSA patients.
  • Topical nasal steroids/decongestants: For coexisting rhinitis/nasal obstruction.

⭐ CPAP is the most effective non-surgical treatment for moderate to severe OSA, significantly reducing AHI and improving sleep quality.

oka

Surgical Interventions - Airway Architects

• Indications: CPAP failure/intolerance, patient preference, identifiable anatomical obstruction, significant craniofacial abnormalities.
• DISE (Drug-Induced Sleep Endoscopy): Crucial for pinpointing obstruction site(s) to tailor surgical approach.
• Site-Specific Surgeries:
  • Nasal:
    • Septoplasty, Turbinoplasty: Corrects nasal septal deviation, reduces turbinate hypertrophy; improves nasal airflow.
  • Palatal:
    • Uvulopalatopharyngoplasty (UPPP), Laser-Assisted Uvulopalatoplasty (LAUP), Expansion Pharyngoplasty: Addresses soft palate and uvula redundancy.
  • Hypopharyngeal/Tongue:
    • Genioglossus Advancement, Hyoid Suspension, Tongue Base Reduction (e.g., radiofrequency): Targets tongue base collapse.
  • Skeletal:
    • Maxillomandibular Advancement (MMA): Advances upper and lower jaws; significantly enlarges airway.
  • Tracheostomy: Definitive; bypasses upper airway obstruction in severe, refractory cases.

⭐ Maxillomandibular Advancement (MMA) generally offers the highest success rates (often >90%) among OSA surgeries.

Pediatrics & Long-Term Care - Lifelong Vigilance

• Pediatric OSA:

  • Presents differently: hyperactivity, enuresis, poor growth, not always loud snoring. Polysomnography (PSG) criteria differ from adults.
  • Commonest cause: Adenotonsillar hypertrophy.

  ⭐ Adenotonsillectomy is the first-line treatment for most pediatric OSA cases.

• Managing Comorbidities:

  • Crucial to address associated conditions: hypertension, cardiovascular risks, diabetes, Gastroesophageal Reflux Disease (GERD).

• Long-Term Vigilance:

  • Essential for all OSA patients.
  • Monitor treatment efficacy (e.g., repeat PSG if symptoms persist/recur), adherence to therapy (e.g., CPAP).
  • Manage side effects; reassess for new symptoms or significant weight changes.

• Bariatric Surgery:

  • An option for significant obesity contributing to OSA, especially if other treatments are insufficient or poorly tolerated in adults; less common in pediatrics but considered in severe adolescent obesity with OSA unresponsive to other treatments after multidisciplinary evaluation.

High‑Yield Points - ⚡ Biggest Takeaways

• OSA management is multidisciplinary, involving ENT, Pulmonology, Neurology, Dentistry, and Dietetics.
• Polysomnography (PSG) is the gold standard for OSA diagnosis.
• CPAP is first-line treatment for moderate to severe OSA.
• Surgery (e.g., UPPP) is for CPAP failure/intolerance or specific anatomy.
• Lifestyle modifications (weight loss, sleep hygiene) are crucial adjuncts.
• Mandibular advancement devices (MADs) suit mild-moderate OSA or CPAP intolerance.